Evertec Inc. Common Stock (EVTC) 15.41 $EVTC EVERTEC to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evertec Inc. Common Stock (EVTC) 15.41 $EVTC

EVERTEC to Present at the William Blair 2016 Growth Stock Conference
BusinessWire - Wed Jun 01, 3:05PM CDT
EVERTEC, Inc. (NYSE: EVTC) ("EVERTEC" or the "Company" today announced that President and Chief Executive Officer, Mac Schuessler, and Executive Vice President and Chief Financial Officer, Peter Smith, will be presenting at the William Blair 36th Annual Growth Stock Conference in Chicago on Wednesday, June 15, 2016 at 12:00 pm CT.
EVTC: 15.41 (-0.87)

EVERTEC Declares Quarterly Dividend on Common Stock
BusinessWire - Wed May 11, 3:11PM CDT
EVERTEC, Inc. (NYSE: EVTC) ("EVERTEC" or the "Company" today announced that its Board of Directors has declared a regular quarterly dividend of $0.10 per share to be paid on June 10, 2016 to stockholders of record as of May 23, 2016.
EVTC: 15.41 (-0.87)

EVERTEC Reports Preliminary First Quarter 2016 Results
BusinessWire - Wed May 11, 3:10PM CDT
EVERTEC, Inc. (NYSE: EVTC) ("EVERTEC" or the "Company" today announced preliminary results for the first quarter ended March 31, 2016. All financial results described in this press release should be considered preliminary. As previously disclosed, the Company was unable to timely file its 2015 Annual Report on Form 10-K for the year ended December 31, 2015 (the "2015 Form 10-K" due to a restatement and will also delay the filing of the Company's 2016 first quarter report on Form 10-Q. The Company is working diligently to complete the restatement to permit the filing of the Company's 2015 Form 10-K and 2016 first quarter Form 10-Q as soon as practicable. The preliminary information here in has been prepared by the Company's management and has not undergone the complete review by the Company's outside auditors that is customary for the release of interim results. The preliminary information represents the Company's good faith belief as to the Company's results for the periods presented, but it is pending any impact from the restatement and investors are cautioned that such information is neither final nor complete and should not be relied on as such.
EVTC: 15.41 (-0.87)

EVERTEC, Inc. to Announce First Quarter 2016 Preliminary Financial Results on May 11, 2016
BusinessWire - Wed Apr 27, 7:00AM CDT
EVERTEC, Inc. (NYSE: EVTC) today announced that it will host a conference call and webcast on Wednesday, May 11, 2016 at 5:00 p.m. ET to review first quarter 2016 preliminary financial results. Participating on the call will be Mac Schuessler, President and Chief Executive Officer, and Peter Smith, Executive Vice President and Chief Financial Officer. A press release with first quarter 2016 preliminary financial results will be issued shortly after the market closes on Wednesday, May 11, 2016.
EVTC: 15.41 (-0.87)

EVERTEC Amends Credit Facility
BusinessWire - Thu Apr 14, 3:05PM CDT
EVERTEC, Inc. (NYSE: EVTC) ("EVERTEC" or the "Company" today announced that its main operating subsidiary, Evertec Group, LLC ("Evertec Group" or the "Borrower", together with certain other subsidiaries of the Company, has entered into an amendment and waiver of its existing credit facility to extend certain financial reporting deadlines.
EVTC: 15.41 (-0.87)

EVERTEC Receives NYSE Notice Regarding Late Form 10-K Filing
BusinessWire - Tue Mar 22, 4:03PM CDT
EVERTEC, Inc. (NYSE: EVTC) ("EVERTEC" or the "Company" announced today that, as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2015 (the "Form 10-K", it has received a notice from the New York Stock Exchange (the "NYSE" that the Company is not in compliance with the NYSE's continued listing requirements under the timely filing criteria established in Section 802.01E of the NYSE Listed Company Manual.
EVTC: 15.41 (-0.87)

EVERTEC, Inc. to Announce Fourth Quarter and Full Year 2015 Financial Results on February 17, 2016
BusinessWire - Fri Jan 22, 7:00AM CST
EVERTEC, Inc. (NYSE: EVTC) today announced that it will host a conference call and webcast on Wednesday, February 17, 2016 at 5:00 p.m. ET to review fourth quarter and full year 2015 financial results. Participating on the call will be Mac Schuessler, President and Chief Executive Officer, and Peter Smith, Executive Vice President and Chief Financial Officer. A press release with fourth quarter and full year 2015 financial results will be issued shortly after the market closes on Wednesday, February 17, 2016.
EVTC: 15.41 (-0.87)

EVERTEC Extends Period for Acquisition of Majority Ownership of Processa, a Colombian Payment Processor
BusinessWire - Mon Dec 28, 3:05PM CST
EVERTEC, Inc. (NYSE: EVTC) today announced that its operating subsidiary, EVERTEC Group, LLC and the selling shareholders of Processa S.A.S agreed to extend the period in which the transaction must close before each party has the right to terminate the purchase agreement. This period, which was set to end on December 28, 2015, has been extended to March 31, 2016. The purchase agreement provides for EVERTEC to acquire 65% of the share capital of Processa S.A.S., a Colombian payment processor company that is based in Bogota. The transaction is subject to customary closing conditions, including receipt of US federal bank regulatory approval. The Company is awaiting regulatory approval. Receipt of US federal bank regulatory approval is dependent on factors outside the control of EVERTEC. There is no assurance that such approval will be obtained prior to March 31, 2016 or at all.
EVTC: 15.41 (-0.87)

EVERTEC Extends Terms of Acquisition of Majority Ownership of Processa, a Colombian Payment Processor
BusinessWire - Mon Nov 30, 11:08AM CST
EVERTEC, Inc. (NYSE: EVTC) today announced that its operating subsidiary, EVERTEC Group, LLC and the selling shareholders of Processa S.A.S agreed to extend the contractually agreed upon period for each of the parties to satisfy all conditions to closing before the purchase agreement becomes terminable for an additional 30 calendar days to December 28, 2015. The purchase agreement provides for EVERTEC to acquire 65% of the share capital of Processa S.A.S., a Colombian company that is based in Bogota. Previously, the purchase agreement provided the right of either EVERTEC or the selling shareholders to terminate the transaction if it had not closed as of November 28, 2015. The transaction is subject to customary closing conditions, including receipt of US federal bank regulatory approval. There is no assurance that such approval will be obtained prior to December 28, 2015 or at all.
EVTC: 15.41 (-0.87)

EVERTEC Reports Third Quarter 2015 Results
BusinessWire - Wed Nov 04, 3:05PM CST
EVERTEC, Inc. (NYSE: EVTC) ("EVERTEC" or the "Company" today announced results for the third quarter ended September 30, 2015.
EVTC: 15.41 (-0.87)

EVERTEC, Inc. to Announce Third Quarter 2015 Financial Results on November 4, 2015
BusinessWire - Wed Oct 14, 3:05PM CDT
EVERTEC, Inc. (NYSE: EVTC) today announced that it will host a conference call and webcast on Wednesday, November 4, 2015 at 5:00 p.m. ET to review third quarter 2015 financial results. Participating on the call will be Mac Schuessler, President and Chief Executive Officer, and Peter Smith, Executive Vice President and Chief Financial Officer. A press release with third quarter 2015 financial results will be issued shortly after the market closes on Wednesday, November 4, 2015.
EVTC: 15.41 (-0.87)

Western Union to Set Up Self Service Kiosks at Walgreens
Zacks Equity Research - Zacks Investment Research - Thu Oct 01, 12:10PM CDT
Western Union Co. (WU) has announced a tie-up with Walgreens, the largest drug chain store in the U.S.
FISV: 103.25 (-2.38), WU: 18.61 (-0.77), EVTC: 15.41 (-0.87), EFX: 122.09 (-4.87)

EVERTEC Agrees to Acquire Majority Ownership of Processa, a Colombian Payment Processor
BusinessWire - Tue Sep 01, 3:01PM CDT
EVERTEC, Inc. (NYSE: EVTC) today announced that its operating subsidiary, EVERTEC Group, LLC, entered into an agreement on August 28, 2015 to purchase 65% of the share capital of Processa S.A.S., a Colombian company that is based in Bogota and engaged in the business of payment processing and supply of related services and equipment in Colombia. The aggregate purchase price for the shares equals approximately COP 16,728 million, or approximately US$5.4 million at current exchange rates, and is subject to customary adjustments.
EVTC: 15.41 (-0.87)

EVERTEC Announces Organizational Changes
BusinessWire - Thu Aug 20, 7:30AM CDT
EVERTEC, Inc. (NYSE:EVTC) ("EVERTEC" or the "Company" today announced the following key organizational changes:
EVTC: 15.41 (-0.87)

First Week of EVTC February 2016 Options Trading
DividendChannel.com - Fri Aug 07, 9:55AM CDT
Investors in Evertec, Inc. saw new options become available this week, for the February 2016 expiration.
EVTC: 15.41 (-0.87)

The Zacks Analyst Blog Highlights: EVERTEC, OFG Bancorp and Popular, Inc - Press Releases
Zacks Equity Research - Zacks Investment Research - Thu Jul 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: EVERTEC, OFG Bancorp and Popular, Inc
OFG: 8.38 (-0.47), BPOP: 28.58 (-1.64), EVTC: 15.41 (-0.87)

Is Bankrupt Puerto Rico America's Greece Crisis? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 08, 8:01AM CDT
The Puerto Rico crisis is no less to keep investors worried
OFG: 8.38 (-0.47), BPOP: 28.58 (-1.64), EVTC: 15.41 (-0.87)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market News: Nasdaq Dips as Applied Materials Shines

Updated Category News Views 191

Stock Market Declines on Nasdaq Today, U.S. stocks faced challenges with the Nasdaq Composite dropping significantly. The market opened lower with declines across major indices, signaling a cautious trading atmosphere. Market Overview As the day progressed, the Dow Jones Industrial Average fell by 1.21% to 46,882.86, while the NASDAQ retreated by 1.51%, settling at...

Continue Reading
Fastly Eyewitness: A Look at Recent Stock Performance

Updated Category News Views 205

Fastly's Impressive Stock Surge Fastly stock has recently shown remarkable movement, trading at near recent highs, indicating strong investor confidence in the company. The notable increase has left many wondering how long this momentum can be sustained. AI Transformation Sparks Interest Shifting Perspectives in Technology The recent ascent of Fastly's stock is largely...

Continue Reading
Exploring the Transformation of Social Media Management Market

Updated Category News Views 139

Understanding the Evolution of the Social Media Management Market The social media management market is experiencing remarkable growth. From a value of $17.5 billion in 2022, projections indicate it may reach $51.8 billion by 2027. This surge represents a compound annual growth rate (CAGR) of 24.2%. Companies worldwide are adapting to the increasing reliance on social...

Continue Reading
WestBond Enterprises Posts Year-End Financial Results and Outlook

Updated Category News Views 166

WestBond Enterprises Financial Overview WestBond Enterprises Corporation (TSX-V: WBE), a notable player in the manufacturing sector, has reported a financial loss of $52,380 for the year ending in March, reflecting a notable decrease from the previous year's loss of $210,683. Despite the loss, the company experienced a 4.9% increase in sales, which totaled $9,673,002,...

Continue Reading
Investors of Ultra Clean Urged to Act Amidst Stock Decline

Updated Category News Views 239

Investigation by Faruqi & Faruqi for Ultra Clean Investors Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors who have experienced losses exceeding $50,000 in Ultra Clean Holdings, Inc. (NASDAQ: UCTT). The firm aims to discuss potential legal options available to these investors following troubling financial disclosures from Ultra...

Continue Reading